2019
DOI: 10.1016/j.bmcl.2018.11.038
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and evaluation of biological activity for dual-acting antibiotics on the basis of azithromycin and glycopeptides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
27
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 18 publications
(27 citation statements)
references
References 31 publications
0
27
0
Order By: Relevance
“…Many studies on the development of dual-acting compounds have been conducted on aminoglycosides by linking these molecules to quinolones, as well as to β-lactam antibiotics, CHL, oxazolidinones, or short amphiphilic peptides. Some dual-acting glycopeptide antibiotics have been synthesized, including β-lactam, macrolide moieties, and fragments of natural antimicrobial peptides [ 6 , 7 , 8 ]. Many of these compounds exhibited a high antibacterial activity not only against Gram-positive strains, but also against Gram-negative bacteria, had a broad spectrum of activity and reduced the toxicity to the mammalian host, compared to the original antibiotics, and were also active against bacterial drug-resistant strains.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Many studies on the development of dual-acting compounds have been conducted on aminoglycosides by linking these molecules to quinolones, as well as to β-lactam antibiotics, CHL, oxazolidinones, or short amphiphilic peptides. Some dual-acting glycopeptide antibiotics have been synthesized, including β-lactam, macrolide moieties, and fragments of natural antimicrobial peptides [ 6 , 7 , 8 ]. Many of these compounds exhibited a high antibacterial activity not only against Gram-positive strains, but also against Gram-negative bacteria, had a broad spectrum of activity and reduced the toxicity to the mammalian host, compared to the original antibiotics, and were also active against bacterial drug-resistant strains.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, benzoxaboroles are known to enhance the transport of macromolecules into the cell as a result of the interaction with 1,2- and 1,3-diol polysaccharides located on the cell surface. These properties, as well as the ability of some heterocyclic boronic acids and benzoxaborole derivatives to exhibit activity against Gram-negative bacteria with multi-drug resistance, were considered when developing chimeric antibiotics based on glycopeptides or polyene macrocyclic antibiotics containing benzoxaboroles in their structure [ 6 , 12 ] and benzoxaborole derivatives of azithromycin [ 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…We have recently designed and prepared novel conjugates of azithromycin, the macrozones, in order to overcome the bacterial resistance mechanisms [12]. Some azithromycin conjugates have already proven useful to treat pathogenic bacteria [13][14][15][16][17][18][19][20][21][22][23][24]. The macrozones, hybrid compounds of azithromycin and thiosemicarbazones, have shown excellent antibacterial activities against susceptible and resistant strains [12].…”
Section: Resultsmentioning
confidence: 99%
“…Many studies on the development of dualacting compounds have been conducted on aminoglycosides by linking these molecules to quinolones, as well as to β-lactam antibiotics, CHL, oxazolidinones, or short amphiphilic peptides. Some dual-acting glycopeptide antibiotics have been synthesized, including β-lactam, macrolide moieties, and fragments of natural antimicrobial peptides [6][7][8]. Many of these compounds exhibited a high antibacterial activity not only against Gram-positive strains, but also against Gram-negative bacteria, had a broad spectrum of activity and reduced the toxicity to the mammalian host, compared to the original antibiotics, and were also active against bacterial drug-resistant strains.…”
Section: Introductionmentioning
confidence: 99%